These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8730830)

  • 1. Cholinergic-glutamatergic interactions in visual recognition memory of rhesus monkeys.
    Matsuoka N; Aigner TG
    Neuroreport; 1996 Jan; 7(2):565-8. PubMed ID: 8730830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glycine/NMDA receptor antagonist HA-966 impairs visual recognition memory in rhesus monkeys.
    Matsuoka N; Aigner TG
    Brain Res; 1996 Aug; 731(1-2):72-8. PubMed ID: 8883856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory avoidance memory deficit induced by scopolamine: Interaction of cholinergic and glutamatergic systems in the ventral tegmental area.
    Mahmoodi G; Ahmadi S; Pourmotabbed A; Oryan S; Zarrindast MR
    Neurobiol Learn Mem; 2010 Jul; 94(1):83-90. PubMed ID: 20403448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK-801 impairs recognition memory in rhesus monkeys: comparison with cholinergic drugs.
    Ogura H; Aigner TG
    J Pharmacol Exp Ther; 1993 Jul; 266(1):60-4. PubMed ID: 8331575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scopolamine impairs auditory delayed matching-to-sample performance in monkeys.
    Plakke B; Ng CW; Poremba A
    Neurosci Lett; 2008 Jun; 438(1):126-30. PubMed ID: 18455309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: comparison with physostigmine.
    Matsuoka N; Aigner TG
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1201-9. PubMed ID: 9067304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scopolamine and MK-801 impair recognition memory in a new spontaneous object exploration task in monkeys.
    Oliveira AWC; Pacheco JVN; Costa CS; Aquino J; Maior RS; Barros M
    Pharmacol Biochem Behav; 2021 Dec; 211():173300. PubMed ID: 34798097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nociceptin orphanin FQ peptide receptor agonist, Ro64-6198, impairs recognition memory formation through interaction with glutamatergic but not cholinergic receptor antagonists.
    Reiss D; Prinssen EP; Wichmann J; Kieffer BL; Ouagazzal AM
    Neurobiol Learn Mem; 2012 Oct; 98(3):254-60. PubMed ID: 22982481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA antagonists potentiate scopolamine-induced amnesic effect.
    Li HB; Matsumoto K; Tohda M; Yamamoto M; Watanabe H
    Behav Brain Res; 1997 Feb; 83(1-2):225-8. PubMed ID: 9062690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects on delayed non-matching-to-position in rats of microinjections of muscarinic receptor antagonist scopolamine or NMDA receptor antagonist MK-801 into the dorsal or ventral extent of the hippocampus.
    Robinson JK; Mao JB
    Brain Res; 1997 Aug; 765(1):51-60. PubMed ID: 9310393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory avoidance memory deficit induced by scopolamine: interaction with glutamatergic system in the nucleus accumbens.
    Pakpour B; Ahmadi S; Nayer-Nouri T; Oryan S; Zarrindast MR
    Behav Pharmacol; 2010 Dec; 21(8):719-26. PubMed ID: 20926947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission.
    Eriksson TM; Madjid N; Elvander-Tottie E; Stiedl O; Svenningsson P; Ogren SO
    Neuropharmacology; 2008 Jun; 54(7):1041-50. PubMed ID: 18394658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between M1-muscarinic and glutamatergic NMDA receptors on an inhibitory avoidance task.
    Monteiro Moreira K; Lima Ferreira T; Vecchio Fornari R; Perez Figueredo LZ; Menezes Oliveira MG
    Brain Res Bull; 2005 Nov; 67(6):504-8. PubMed ID: 16216700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys.
    Matsuoka N; Aigner TG
    J Pharmacol Exp Ther; 1996 Aug; 278(2):891-7. PubMed ID: 8768744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactive effects of morphine and scopolamine, MK-801, propanolol on spatial working memory in rhesus monkeys.
    Wang J; Chen Y; Carlson S; Li L; Hu X; Ma Y
    Neurosci Lett; 2012 Aug; 523(2):119-24. PubMed ID: 22750153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between glutamatergic-NMDA and cholinergic-muscarinic systems in classical fear conditioning.
    Figueredo LZ; Moreira KM; Ferreira TL; Fornari RV; Oliveira MG
    Brain Res Bull; 2008 Sep; 77(2-3):71-6. PubMed ID: 18582541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of NMDA receptors in the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice.
    Almasi-Nasrabadi M; Javadi-Paydar M; Mahdavian S; Babaei R; Sharifian M; Norouzi A; Dehpour AR
    Behav Brain Res; 2012 May; 231(1):138-45. PubMed ID: 22440233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent administration of subeffective doses of scopolamine and MK-801 produces a short-term amnesia for the elevated plus-maze in mice.
    Hlinák Z; Krejcí I
    Behav Brain Res; 1998 Mar; 91(1-2):83-9. PubMed ID: 9578442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys.
    Tsukada H; Nishiyama S; Fukumoto D; Sato K; Kakiuchi T; Domino EF
    Neuropsychopharmacology; 2005 Oct; 30(10):1861-9. PubMed ID: 15841110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeys.
    Taffe MA; Weed MR; Gutierrez T; Davis SA; Gold LH
    Psychopharmacology (Berl); 2002 Mar; 160(3):253-62. PubMed ID: 11889494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.